Journal of Internal Medicine Concepts & Practice ›› 2024, Vol. 19 ›› Issue (04): 264-268.doi: 10.16138/j.1673-6087.2024.04.09
• Review • Previous Articles Next Articles
TIAN Ruochen1, LI Jing2
Received:
2024-05-31
Online:
2024-08-28
Published:
2024-11-11
CLC Number:
TIAN Ruochen, LI Jing. Research progress on agranulocytosis caused by antithyroid drugs[J]. Journal of Internal Medicine Concepts & Practice, 2024, 19(04): 264-268.
[1] | Azizi F, Abdi H, Mehran L, et al. Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves’ disease: a systematic scoping review[J]. J Endocrinol Invest, 2022, 45(6):1139-1150. |
[2] | 陈诗, 刘庆阳, 朱艳. 甲状腺功能异常与肝损害相关性研究进展[J]. 中国实用内科杂志, 2023, 43(02):165-170. |
[3] | Azizi F. Long-term treatment of hyperthyroidism with antithyroid drugs: 35 years of personal clinical experience[J]. Thyroid, 2020, 30(10):1451-1457. |
[4] | Li J, Zhang X, Li L, et al. Risk factors for granulocytopenia in patients with Graves’ disease receiving antithyroid drugs[J]. Int J Endocrinol, 2023,2023:9935195. |
[5] | Harshman LA, Williams R, Engen RM. Neutropenia in pediatric solid organ transplant[J]. Pediatr Transplant, 2022, 26(8):e14378. |
[6] | Kamitani F, Nishioka Y, Koizumi M, et al. Antithyroid drug-induced leukopenia and G-CSF administration: a long-term cohort study[J]. Sci Rep, 2023, 13(1):19336. |
[7] | El-shreIif HJ. Agranulocytosis: a rare complication of the thionamides[J]. Egypt J Intern Med, 2023, 35(1): 59. |
[8] | Tseng CH, Tseng CL, Chen HS, et al. Clinical characteristics of neutropenic patients under antithyroid drug: twelve-year experience in a medical center[J]. J Chin Med Assoc, 2023, 86(9):826-834. |
[9] |
Cheetham T. How to use thionamide anti-thyroid drug in the young- what’s new?[J]. Thyroid Res, 2021, 14(1):18.
doi: 10.1186/s13044-021-00109-x pmid: 34289872 |
[10] |
Vicente N, Cardoso L, Barros L, et al. Antithyroid drug-induced agranulocytosis: state of the art on diagnosis and management[J]. Drugs R D, 2017, 17(1):91-96.
doi: 10.1007/s40268-017-0172-1 pmid: 28105610 |
[11] | Lee HG, Yang EM, Kim CJ. Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease[J]. Ann Pediatr Endocrinol Metab, 2021, 26(3):199-204. |
[12] | Karmisholt J, Andersen SL, Bulow-Pedersen I, et al. Long-term methimazole therapy in Graves’ hyperthyroidism and adverse reactions: a Danish multicenter study[J]. Eur Thyroid J, 2022, 11(3):e220031. |
[13] | Chaudhry LA, Mauzen KF, Ba-Essa E, et al. Antithyroid drug induced a granulocytosis: what still we need to learn?[J]. Pan Afr Med J, 2016,23:27. |
[14] | Hossam Abdelmonem B, Abdelaal NM, Anwer EKE, et al. Decoding the role of CYP450 enzymes in metabolism and disease: a comprehensive review[J]. Biomedicines, 2024, 12(7):1467. |
[15] | Rizo-Téllez SA, Sekheri M, Filep JG. Myeloperoxidase: regulation of neutrophil function and target for therapy[J]. Antioxidants (Basel), 2022, 11(11):2302. |
[16] |
Venkatakrishnan V, Elmwall J, Lahiri T, et al. Novel inhibitory effect of galectin-3 on the respiratory burst induced by staphylococcus aureus in human neutrophils[J]. Glycobiology, 2023, 33(6):503-511.
doi: 10.1093/glycob/cwad032 pmid: 37073717 |
[17] | Ramani S, Pathak A, Dalal V, et al. Oxidative stress in autoimmune diseases: an under dealt malice[J]. Curr Protein Pept Sci, 2020, 21(6):611-621. |
[18] |
Schmidt F, Wolf R, Baumann L, et al. Ultrastructural alterations in thyrocytes of zebrafish ( danio rerio) after exposure to propylthiouracil and perchlorate[J]. Toxicol Pathol, 2017, 45(5):649-662.
doi: 10.1177/0192623317721748 pmid: 28830330 |
[19] |
Yazıcı Ö, Kara M, Boran T, et al. The role of endoplasmic reticulum stress in cell injury induced by methimazole on pancreatic cells[J]. Adv Pharm Bull, 2023, 13(1):196-201.
doi: 10.34172/apb.2023.042 pmid: 36721818 |
[20] | Harper L, Chin L, Daykin J, et al. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves’ disease[J]. Clin Endocrinol (Oxf), 2004, 60(6):671-675. |
[21] | Johnston A, Uetrecht J. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis[J]. Expert Opin Drug Metab Toxicol, 2015, 11(2):243-257. |
[22] |
Litao MKS, Alvarez AG, Shah B. Pre-treatment neutropenia in children and adolescents with autoimmune hyperthyroidism[J]. J Clin Res Pediatr Endocrinol, 2021, 13(3):263-268.
doi: 10.4274/jcrpe.galenos.2020.2020.0184 pmid: 33261249 |
[23] | Lee H, Jose PA. Coordinated contribution of NADPH oxidase- and mitochondria-derived reactive oxygen species in metabolic syndrome and its implication in renal dysfunction[J]. Front Pharmacol, 2021,12:670076. |
[24] | Camacho V, Kuznetsova V, Welner RS. Inflammatory cytokines shape an altered immune response during myeloid malignancies[J]. Front Immunol, 2021,12:772408. |
[25] | Su B, Ren Y, Yao W, et al. Mitochondrial dysfunction and NLRP3 inflammasome: key players in kidney stone formation[J]. BJU Int, 2024. [Epub ahead of print]. |
[26] | Blevins HM, Xu Y, Biby S, et al. The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases[J]. Front Aging Neurosci, 2022,14:879021. |
[27] | Wang L, Hauenstein AV. The NLRP3 inflammasome: mechanism of action, role in disease and therapies[J]. Mol Aspects Med, 2020,76:100889. |
[28] | Yu X, Hu Y, Wu Y, et al. The c-Myc-regulated miR-17-92 cluster mediates ATRA-induced APL cell differentiation[J]. Asia Pac J Clin Oncol, 2019, 15(6):364-370. |
[29] |
Yang J, Lv Y, Zhang Y, et al. Decreased miR-17-92 cluster expression level in serum and granulocytes preceding onset of antithyroid drug-induced agranulocytosis[J]. Endocrine, 2018, 59(1):218-225.
doi: 10.1007/s12020-017-1481-4 pmid: 29255972 |
[30] | Ramsbottom KA, Carr DF, Rigden DJ, et al. Informatics investigations into anti-thyroid drug induced agranulocytosis associated with multiple HLA-B alleles[J]. PLoS One, 2020, 15(2):e0220754. |
[31] | Chen WT, Chi CC. Associations of HLA genotypes with antithyroid drug-induced agranulocytosis: a systematic review and meta-analysis of pharmacogenomics studies[J]. Br J Clin Pharmacol, 2019, 85(9):1878-1887. |
[32] | Kamal S, Kerndt CC, Lappin SL. Genetics, histocompatibility antigen[M/OL]. 2023. https://www.ncbi.nlm.nih.gov/books/NBK541023/. |
[33] | Chen PL, Shih SR, Wang PW, et al. Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study[J]. Nat Commun, 2015,6:7633. |
[34] | He Y, Zheng J, Zhang Q, et al. Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern China[J]. Sci Rep, 2017, 7(1):11950. |
[35] | Hallberg P, Eriksson N, Ibañez L, et al. Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population[J]. Lancet Diabetes Endocrinol, 2016, 4(6):507-516. |
[36] |
Jarolímová M, Kazmíř M. Závažná autoimunitní tyreotoxikóza komplikovaná febrilní neutropenií jako nežádoucí účinek tyreostatické léčby [Severe autoimune thyreotoxicosis complicated by febrile neutropenia as a result of thyreostatic therapy][J]. Vnitr Lek, 2023, 69(E-2):19-22.
doi: 10.36290/vnl.2023.024 pmid: 37072262 |
[37] | Toledo-Stuardo K, Ribeiro CH, Canals A, et al. Major histocompatibility complex class i-related chain A (MICA) allelic variants associate with susceptibility and prognosis of gastric cancer[J]. Front Immunol, 2021,12:645528. |
[38] | Ma P, Chen P, Gao J, et al. Association of MICA gene polymorphisms with thionamide-induced agranulocytosis[J]. J Endocrinol Invest, 2021, 44(2):363-369. |
[39] | Gong X, Chen P, Ma P, et al. MICA polymorphisms associated with antithyroid drug-induced agranulocytosis in the Chinese Han population[J]. Immun Inflamm Dis, 2020, 8(4):695-703. |
[40] | He Y, Ma P, Luo Y, et al. Novel association of KLRC4-KLRK1 gene polymorphisms with susceptibility and progression of antithyroid drug-induced agranulocytosis[J]. Exp Clin Endocrinol Diabetes, 2024, 132(1):17-22. |
[41] |
Sooda A, Rwandamuriye F, Wanjalla CN, et al. Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors[J]. Commun Biol, 2022, 5(1):133.
doi: 10.1038/s42003-022-03058-9 pmid: 35173258 |
[42] | Pan RY, Chu MT, Wang CW, et al. Identification of drug-specific public TCR driving severe cutaneous adverse reactions[J]. Nat Commun, 2019, 10(1):3569. |
[43] |
Plantinga TS, Arts P, Knarren GH, et al. Rare NOX3 variants confer susceptibility to agranulocytosis during thyrostatic treatment of Graves’ disease[J]. Clin Pharmacol Ther, 2017, 102(6):1017-1024.
doi: 10.1002/cpt.733 pmid: 28486791 |
[44] | Kang Z, Fu P, Ma H, et al. Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy[J]. bioRxiv, 2023.[Epub ahead of print]. |
[45] | Jin S, Li X, Fan Y, et al. Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury[J]. Basic Clin Pharmacol Toxicol, 2019, 125(6):508-517. |
[46] |
Phillips IR, Shephard EA. Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease[J]. Xenobiotica, 2020, 50(1):19-33.
doi: 10.1080/00498254.2019.1643515 pmid: 31317802 |
[47] | He YY, Hasan AME, Zhang Q, et al. Novel association between flavin-containing monooxygenase 3 gene polymorphism and antithyroid drug-induced agranulocytosis in the han population[J]. Ann Nutr Metab, 2019, 74(3):200-206. |
[1] | CHEN Heng, WANG Jue, ZHOU Xu. Research progress on the mechanism of skin aging caused by ultraviolet radiation [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2024, 20(3): 382-. |
[2] | Wei Guo, Linhui Yu, Ling Tang, Yan Wan, Yangming Lin. Recent Advances in Mechanistic Understanding of Metal-Free Carbon Thermocatalysis and Electrocatalysis with Model Molecules [J]. Nano-Micro Letters, 2024, 16(1): 125-. |
[3] | YANG Ao, ZHANG Peiheng, ZHANG Yang, GAO Ying. Impact of maternal hyperthyroidism during pregnancy on neurological and psychiatric development of offspring [J]. Journal of Internal Medicine Concepts & Practice, 2024, 19(04): 269-272. |
[4] | YUAN Yueyang1* (袁越阳),CHEN Yuqing2 (陈宇清),ZHOU Lil(周理), LIU Wei3 (刘炜), DAI Zheng3(戴 征). Gas Exchange Mechanism of High Frequency Ventilation: A Brief Narrative Review and Prospect [J]. J Shanghai Jiaotong Univ Sci, 2023, 28(4): 546-. |
[5] | XU Bojin, PENG Wenfang, HUANG Shan. Interpretation of the 2022 edition of “guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis in China” [J]. Journal of Surgery Concepts & Practice, 2023, 28(06): 512-519. |
[6] | SHEN Pinghua, CHEN Huifen. Advances in mechanism study on novel tetracycline-inactivating enzymes tet(X) causing emerging tigecycline resistance [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(01): 75-79. |
[7] | Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestions on the management of hyperthyroidism and hypothyroidism in the time of COVID-19 [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 128-129. |
[8] | GUO Zhenghong,ZHANG Zheng,ZHANG Yixin,Cosmetic Laser Center. Advances of Laser Techniques in the Treatment of Pathological Scars [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2018, 14(3): 168-173. |
[9] | . [J]. Machine Design & Research, 2018, 34(04): 54-61+69. |
[10] | . [J]. Journal of Internal Medicine Concepts & Practice, 2017, 12(04): 283-287. |
[11] | . [J]. Machine Design & Research, 2017, 33(04): 6-10+21. |
[12] | . [J]. Journal of Internal Medicine Concepts & Practice, 2015, 10(06): 439-443. |
[13] | . [J]. Machine Design & Research, 2015, 31(01): 14-16+21. |
[14] | . [J]. Machine Design & Research, 2014, 30(03): 38-41. |
[15] | . [J]. Journal of Diagnostics Concepts & Practice, 2012, 11(03): 252-257. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||